Cerus Corporation (CERS)
NASDAQ
Closed
Aug 24, 2026
Day's Range
2.6952 wk Range
1.17Overview - CERS - Cerus Corporation
Key Statistics
Valuation
Enterprise Value
587.51M
P/E (Trailing)
‪-33.62‬
P/E (Forward)
‪-562.00‬
PEG Ratio
‪0.50‬
Price / Sales (TTM)
‪2.55‬
Price / Book
‪8.07‬
EV / EBITDA
‪8,901.68‬
Profitability
Gross Margin
‪51.41%‬
Profit Margin
‪-3.06%‬
Operating Margin
‪-3.23%‬
Return on Assets
‪-0.48%‬
Return on Equity
‪-10.77%‬
Ownership
Shares Outstanding
201.45M
Float
195.34M
Short % of Shares Outstanding
‪7.64%‬
Held by Insiders
‪3.61%‬
Held by Institutions
‪73.32%‬
Price stats
Beta
‪1.77‬
50-Day Avg
‪2.81‬
200-Day Avg
‪2.31‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
3 analysts
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CERS - Cerus Corporation
Peers - CERS - Cerus Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
- CERSNASDAQCerus Corporation566.28MMarket Cap+54.45%52-week change-35.00P/E (Trailing)‪-3.06%‬Profit Margin
- DXCMNASDAQDexCom, Inc.34.84BMarket Cap+17.74%52-week change37.38P/E (Trailing)‪20.11%‬Profit Margin
- GEHCNASDAQGE HealthCare Technologies Inc.33.79BMarket Cap+0.31%52-week change17.24P/E (Trailing)‪9.33%‬Profit Margin
- PODDNASDAQInsulet Corporation10.27BMarket Cap-122.06%52-week change27.80P/E (Trailing)‪12.29%‬Profit Margin
- TLTNASDAQiShares 20+ Year Treasury Bond ETF9.46BMarket Cap-5.03%52-week change—P/E (Trailing)—Profit Margin
- BRKRNASDAQBruker Corporation9.07BMarket Cap+41.89%52-week change74.88P/E (Trailing)‪-2.03%‬Profit Margin
- LILIVNNASDAQLivaNova PLC4.32BMarket Cap+28.16%52-week change23.23P/E (Trailing)‪12.81%‬Profit Margin
Profile Summary - CERS - Cerus Corporation
About
Cerus Corporation is a biomedical products company dedicated to enhancing blood transfusion safety through its INTERCEPT Blood System. This platform inactivates a broad range of pathogens, including viruses, bacteria, and parasites, in blood components to reduce the risk of transfusion-transmitted infections. The…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
